Yeast transformation and induction

JS Joseph S. Snowden
JA Jehad Alzahrani
LS Lee Sherry
MS Martin Stacey
DR David J. Rowlands
NR Neil A. Ranson
NS Nicola J. Stonehouse
request Request a Protocol
ask Ask a question
Favorite

While the focus of this work was FAS, which is constitutively expressed in yeast33, our initial aim was to use yeast to express and purify VLPs composed of hepatitis B virus tandem core proteins27 with a SUMO-binding affimer28 inserted into the major immunodominant region (MIR) (construct available upon request) for structural characterisation. As such, VLP expression was induced in the transformed yeast prior to purification, as described previously37. Briefly, glycerol stocks known to exhibit good levels of expression were cultured in yeast extract-peptone-dextrose (YPD), supplemented with 50 µg/mL ampicillin, at 28 °C, 250 rpm for 48 h. 2 ml of the high-density starter culture was then transferred to 200 mL YPD and incubated for another 24 h under the same conditions. To induce expression of VLPs, cells were pelleted (1500 × g, 20 min) and resuspended in 200 mL yeast extract-peptone-methanol (YPM; 0.5% [v/v] methanol) for a further 48-h incubation, with methanol added to a final concentration of 0.5% (v/v) 24 h post-induction. Cells were subsequently collected by pelleting at 2000×g (20 min), resuspended in 30 mL breaking buffer (50 mM sodium phosphate, 1 mM phenylmethylsulfonyl fluoride [PMSF], 1 mM EDTA, 5% glycerol, pH 7.4) and stored at − 20 °C prior to purification.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A